Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

NCT02992652 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT02992652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02992652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
December 31, 2014
Enrollment
100 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endoscopic retrograde cholangiopancreatography